Skip to main content

Advertisement

SpringerLink
Log in

Discoidin domain receptor 1 is associated with poor prognosis of non-small cell lung cancer and promotes cell invasion via epithelial-to-mesenchymal transition

  • Original Paper
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

Discoidin domain receptors (DDRs) are a novel class of receptor tyrosine kinases that respond to several collagens and facilitate cell adhesion. DDR1 is highly expressed in a variety of human cancers, and it is clear that DDR1 is primarily expressed in epithelial cells including lung, colon and brain. Moreover, DDR1 expression can be stimulated by collagen types I, II, III, IV, V, VIII and XI, and aberrant signaling induced by DDR1 dysregulated expression is involved in various steps of tumorigenesis. However, the molecular mechanism underlying the role of DDR1 in cancer development is not well documented. In this study, we found that the expression of DDR1 is upregulated in non-small cell lung cancer (NSCLC) tissues and cells when compared with counterpart normal tissues and cells. Furthermore, collagen I could induce DDR1 expression, and activated DDR1 promoted NSCLC cell migration and invasion, while knockdown of DDR1 by transfection with siRNA resulted in a significant decrease in cell migrativeness and invasiveness. Enhanced DDR1 expression mediated by collagen I could activate MMP-2, N-cadherin and vimentin expression, but reduce E-cadherin expression; however, inhibition of DDR1 expression could suppress MMP-2, N-cadherin and vimentin expression and induce E-cadherin activation. In conclusion, our findings indicated that upregulation of DDR1 induced by collagen I may contribute to the development and progression of NSCLC and this effect may be associated with increased invasiveness, at least in part, via promoting epithelial-to-mesenchymal transition.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics. CA Cancer J Clin. 2010;60(5):277–300. doi:10.3322/caac.20073.

    Article  PubMed  Google Scholar 

  2. Carney DN. Lung cancer–time to move on from chemotherapy. N Engl J Med. 2002;346(2):126–8. doi:10.1056/NEJM200201103460211.

    Article  PubMed  Google Scholar 

  3. Alves F, Vogel W, Mossie K, Millauer B, Hofler H, Ullrich A. Distinct structural characteristics of discoidin I subfamily receptor tyrosine kinases and complementary expression in human cancer. Oncogene. 1995;10(3):609–18.

    PubMed  CAS  Google Scholar 

  4. Medici D, Nawshad A. Type I collagen promotes epithelial-mesenchymal transition through ILK-dependent activation of NF-kappaB and LEF-1. Matrix Biol. 2010;29(3):161–5. doi:10.1016/j.matbio.2009.12.003.

    Article  PubMed  CAS  Google Scholar 

  5. Ongusaha PP, Kim JI, Fang L, Wong TW, Yancopoulos GD, Aaronson SA, et al. p53 induction and activation of DDR1 kinase counteract p53-mediated apoptosis and influence p53 regulation through a positive feedback loop. EMBO J. 2003;22(6):1289–301. doi:10.1093/emboj/cdg129.

    Article  PubMed  CAS  Google Scholar 

  6. Vogel W, Gish GD, Alves F, Pawson T. The discoidin domain receptor tyrosine kinases are activated by collagen. Mol Cell. 1997;1(1):13–23.

    Article  PubMed  CAS  Google Scholar 

  7. Ram R, Lorente G, Nikolich K, Urfer R, Foehr E, Nagavarapu U. Discoidin domain receptor-1a (DDR1a) promotes glioma cell invasion and adhesion in association with matrix metalloproteinase-2. J Neurooncol. 2006;76(3):239–48. doi:10.1007/s11060-005-6874-1.

    Article  PubMed  CAS  Google Scholar 

  8. Hou G, Vogel W, Bendeck MP. The discoidin domain receptor tyrosine kinase DDR1 in arterial wound repair. J Clin Invest. 2001;107(6):727–35. doi:10.1172/JCI10720.

    Article  PubMed  CAS  Google Scholar 

  9. Vogel WF, Aszodi A, Alves F, Pawson T. Discoidin domain receptor 1 tyrosine kinase has an essential role in mammary gland development. Mol Cell Biol. 2001;21(8):2906–17. doi:10.1128/MCB.21.8.2906-2917.2001.

    Article  PubMed  CAS  Google Scholar 

  10. Johnson JD, Edman JC, Rutter WJ. A receptor tyrosine kinase found in breast carcinoma cells has an extracellular discoidin I-like domain. Proc Natl Acad Sci USA. 1993;90(22):10891.

    Article  PubMed  CAS  Google Scholar 

  11. Heinzelmann-Schwarz VA, Gardiner-Garden M, Henshall SM, Scurry J, Scolyer RA, Davies MJ, et al. Overexpression of the cell adhesion molecules DDR1, Claudin 3, and Ep-CAM in metaplastic ovarian epithelium and ovarian cancer. Clin Cancer Res. 2004;10(13):4427–36. doi:10.1158/1078-0432.CCR-04-0073.

    Article  PubMed  CAS  Google Scholar 

  12. Yang SH, Baek HA, Lee HJ, Park HS, Jang KY, Kang MJ, et al. Discoidin domain receptor 1 is associated with poor prognosis of non-small cell lung carcinomas. Oncol Rep. 2010;24(2):311–9.

    PubMed  CAS  Google Scholar 

  13. Shimada K, Nakamura M, Ishida E, Higuchi T, Yamamoto H, Tsujikawa K, et al. Prostate cancer antigen-1 contributes to cell survival and invasion though discoidin receptor 1 in human prostate cancer. Cancer Sci. 2008;99(1):39–45. doi:10.1111/j.1349-7006.2007.00655.x.

    PubMed  CAS  Google Scholar 

  14. Ford CE, Lau SK, Zhu CQ, Andersson T, Tsao MS, Vogel WF. Expression and mutation analysis of the discoidin domain receptors 1 and 2 in non-small cell lung carcinoma. Br J Cancer. 2007;96(5):808–14. doi:10.1038/sj.bjc.6603614.

    Article  PubMed  CAS  Google Scholar 

  15. Kamohara H, Yamashiro S, Galligan C, Yoshimura T. Discoidin domain receptor 1 isoform-a (DDR1alpha) promotes migration of leukocytes in three-dimensional collagen lattices. FASEB J. 2001;15(14):2724–6. doi:10.1096/fj.01-0359fje.

    PubMed  CAS  Google Scholar 

  16. Zerlin M, Julius MA, Goldfarb M. NEP: a novel receptor-like tyrosine kinase expressed in proliferating neuroepithelia. Oncogene. 1993;8(10):2731–9.

    PubMed  CAS  Google Scholar 

  17. L’Hote CG, Thomas PH, Ganesan TS. Functional analysis of discoidin domain receptor 1: effect of adhesion on DDR1 phosphorylation. FASEB J. 2002;16(2):234–6. doi:10.1096/fj.01-0414fje.

    PubMed  Google Scholar 

  18. Park HS, Kim KR, Lee HJ, Choi HN, Kim DK, Kim BT, et al. Overexpression of discoidin domain receptor 1 increases the migration and invasion of hepatocellular carcinoma cells in association with matrix metalloproteinase. Oncol Rep. 2007;18(6):1435–41.

    PubMed  CAS  Google Scholar 

  19. Ruiz PA, Jarai G. Collagen I induces discoidin domain receptor (DDR) 1 expression through DDR2 and a JAK2-ERK1/2-mediated mechanism in primary human lung fibroblasts. J Biol Chem. 2011;286(15):12912–23. doi:10.1074/jbc.M110.143693.

    Article  PubMed  CAS  Google Scholar 

  20. Koenig A, Mueller C, Hasel C, Adler G, Menke A. Collagen type I induces disruption of E-cadherin-mediated cell–cell contacts and promotes proliferation of pancreatic carcinoma cells. Cancer Res. 2006;66(9):4662–71. doi:10.1158/0008-5472.CAN-05-2804.

    Article  PubMed  CAS  Google Scholar 

  21. Shintani Y, Hollingsworth MA, Wheelock MJ, Johnson KR. Collagen I promotes metastasis in pancreatic cancer by activating c-Jun NH(2)-terminal kinase 1 and up-regulating N-cadherin expression. Cancer Res. 2006;66(24):11745–53. doi:10.1158/0008-5472.CAN-06-2322.

    Article  PubMed  CAS  Google Scholar 

  22. Maeda M, Johnson KR, Wheelock MJ. Cadherin switching: essential for behavioral but not morphological changes during an epithelium-to-mesenchyme transition. J Cell Sci. 2005;118(Pt 5):873–87. doi:10.1242/jcs.01634.

    Article  PubMed  CAS  Google Scholar 

  23. Kang Y, Massague J. Epithelial-mesenchymal transitions: twist in development and metastasis. Cell. 2004;118(3):277–9. doi:10.1016/j.cell.2004.07.011.

    Article  PubMed  CAS  Google Scholar 

  24. Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell. 2009;139(5):871–90. doi:10.1016/j.cell.2009.11.007.

    Article  PubMed  CAS  Google Scholar 

  25. Acloque H, Thiery JP, Nieto MA. The physiology and pathology of the EMT. Meeting on the epithelial-mesenchymal transition. EMBO Rep. 2008;9(4):322–6. doi:10.1038/embor.2008.30.

    Article  PubMed  CAS  Google Scholar 

  26. Lee JM, Dedhar S, Kalluri R, Thompson EW. The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol. 2006;172(7):973–81. doi:10.1083/jcb.200601018.

    Article  PubMed  CAS  Google Scholar 

  27. Zavadil J, Bottinger EP. TGF-beta and epithelial-to-mesenchymal transitions. Oncogene. 2005;24(37):5764–74. doi:10.1038/sj.onc.1208927.

    Article  PubMed  CAS  Google Scholar 

  28. Bremnes RM, Veve R, Gabrielson E, Hirsch FR, Baron A, Bemis L, et al. High-throughput tissue microarray analysis used to evaluate biology and prognostic significance of the E-cadherin pathway in non-small-cell lung cancer. J Clin Oncol. 2002;20(10):2417–28.

    Article  PubMed  CAS  Google Scholar 

  29. Liu D, Huang C, Kameyama K, Hayashi E, Yamauchi A, Kobayashi S et al. E-cadherin expression associated with differentiation and prognosis in patients with non-small cell lung cancer. Ann Thorac Surg. 2001;71(3):949–54; discussion 54–5.

    Google Scholar 

Download references

Acknowledgments

This research was supported by the Natural Science Fund of Jiangsu Province (BK2011658) to Song Yong.

Conflict of interest

The authors declare that they have no competing interests.

Author information

Authors and Affiliations

  1. Department of Respiratory Medicine, Nanjing Drum Tower Hospital Affiliated to Medical School of Nanjing University, 321 Zhongshan Road, Nanjing, 210008, China

    Liyun Miao, Yongsheng Wang, Yan Li, Jingjing Ding, Jinghong Dai, Hourong Cai & Deping Zhang

  2. Department of Respiratory Medicine, Jinling Hospital, Medical School of Nanjing University, 305 East Zhongshan Road, Nanjing, 210002, Jiangsu Province, China

    Suhua Zhu & Yong Song

Authors
  1. Liyun Miao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Suhua Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yongsheng Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yan Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jingjing Ding
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jinghong Dai
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hourong Cai
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Deping Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Yong Song
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yong Song.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Miao, L., Zhu, S., Wang, Y. et al. Discoidin domain receptor 1 is associated with poor prognosis of non-small cell lung cancer and promotes cell invasion via epithelial-to-mesenchymal transition. Med Oncol 30, 626 (2013). https://doi.org/10.1007/s12032-013-0626-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12032-013-0626-4

Keywords

Search

Navigation